Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa A Jackson

Showing results (21-30 of 246) with videos related to

Pageof 25
Sort By:
Journal of Clinical Epidemiology|January 7, 2009
New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniorsJennifer Clark Nelson, Michael L Jackson, Noel S Weiss, et al.
Human Vaccines|April 3, 2008
Changes in DT vaccine frequency and indications for use following introduction of DTaP vaccinePatti J Benson, Lisa A Jackson, Thomas G Rees, et al.
Archives of Internal Medicine|July 25, 2007
To rule out confounding, observational studies of influenza vaccine need to include analyses during the "preinfluenza period"Michael L Jackson, Noel S Weiss, Jennifer C Nelson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2011
Salicylic acid mediates the reduced growth of lignin down-regulated plantsLina Gallego-Giraldo, Luis Escamilla-Trevino, Lisa A Jackson, et al.
The Journal of Infectious Diseases|April 6, 2005
Burden of community-onset Escherichia coli bacteremia in seniorsLisa A Jackson, Patti Benson, Kathleen M Neuzil, et al.
BMC Infectious Diseases|March 27, 2009
Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink studyLisa A Jackson, Roger Baxter, Allison L Naleway, et al.
Vaccine|June 26, 2012
Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50 yearsDerek Weycker, Reiko Sato, David Strutton, et al.
Vaccine|January 16, 2013
Cost-effectiveness of adult pneumococcal vaccination: response to Grabenstein et alDerek Weycker, Reiko Sato, David Strutton, et al.
The Lancet. Infectious Diseases|September 28, 2007
Mortality benefits of influenza vaccination in elderly people: an ongoing controversyLone Simonsen, Robert J Taylor, Cecile Viboud, et al.
Vaccine|May 24, 2018
A phase 1 study of safety and immunogenicity following intradermal administration of a tetravalent dengue vaccine candidateLisa A Jackson, Richard Rupp, Athanasia Papadimitriou, et al.
Pageof 25

Showing results (21-30 of 246) with videos related to

Sort By:
Pageof 25
Journal of Clinical Epidemiology|January 7, 2009
New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniorsJennifer Clark Nelson, Michael L Jackson, Noel S Weiss, et al.
Human Vaccines|April 3, 2008
Changes in DT vaccine frequency and indications for use following introduction of DTaP vaccinePatti J Benson, Lisa A Jackson, Thomas G Rees, et al.
Archives of Internal Medicine|July 25, 2007
To rule out confounding, observational studies of influenza vaccine need to include analyses during the "preinfluenza period"Michael L Jackson, Noel S Weiss, Jennifer C Nelson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2011
Salicylic acid mediates the reduced growth of lignin down-regulated plantsLina Gallego-Giraldo, Luis Escamilla-Trevino, Lisa A Jackson, et al.
The Journal of Infectious Diseases|April 6, 2005
Burden of community-onset Escherichia coli bacteremia in seniorsLisa A Jackson, Patti Benson, Kathleen M Neuzil, et al.
BMC Infectious Diseases|March 27, 2009
Patterns of pneumococcal vaccination and revaccination in elderly and non-elderly adults: a Vaccine Safety Datalink studyLisa A Jackson, Roger Baxter, Allison L Naleway, et al.
Vaccine|June 26, 2012
Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50 yearsDerek Weycker, Reiko Sato, David Strutton, et al.
Vaccine|January 16, 2013
Cost-effectiveness of adult pneumococcal vaccination: response to Grabenstein et alDerek Weycker, Reiko Sato, David Strutton, et al.
The Lancet. Infectious Diseases|September 28, 2007
Mortality benefits of influenza vaccination in elderly people: an ongoing controversyLone Simonsen, Robert J Taylor, Cecile Viboud, et al.
Vaccine|May 24, 2018
A phase 1 study of safety and immunogenicity following intradermal administration of a tetravalent dengue vaccine candidateLisa A Jackson, Richard Rupp, Athanasia Papadimitriou, et al.
Pageof 25